About: Need for long-term anticoagulant treatment in symptomatic calf-vein thrombosis

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Need for long-term anticoagulant treatment in symptomatic calf-vein thrombosis Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 September 1985

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована у вересні 1985 (uk) im September 1985 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu en setiembre de 1985 (ast) scientific article published on 01 September 1985 (en)
publication date	wds:Q69868927-51857937-51AC-4DD0-AD13-7D662936DD73
publication date	1985-09-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q69868927-5B48E805-71EA-4D54-B8D9-71A1A38EC35E
language of work or name	English
author name string	wds:Q69868927-28924CED-2C23-4B22-B925-11972A277B6A wds:Q69868927-60325039-86CE-4EC3-8065-B522FA00605B wds:Q69868927-847D1BFB-F800-4D82-9AA2-47EDBF258276 wds:Q69868927-C71DCD5E-9962-4EA7-8352-0CEF23689B28 wds:Q69868927-E7B57CA0-2A1B-4FEA-B3D8-B5140F4555F4
author name string	C G Olsson U Albrechtsson B W Oqvist B O Fagher C I Lagerstedt
rdfs:label	Need for long-term anticoagulant treatment in symptomatic calf-vein thrombosis (en) Need for long-term anticoagulant treatment in symptomatic calf-vein thrombosis (nl)
skos:prefLabel	Need for long-term anticoagulant treatment in symptomatic calf-vein thrombosis (en) Need for long-term anticoagulant treatment in symptomatic calf-vein thrombosis (nl)
name	Need for long-term anticoagulant treatment in symptomatic calf-vein thrombosis (en) Need for long-term anticoagulant treatment in symptomatic calf-vein thrombosis (nl)
title	wds:Q69868927-AB9B8288-8D28-452A-9893-4A40EADF8361
title	Need for long-term anticoagulant treatment in symptomatic calf-vein thrombosis (en)
page(s)	wds:Q69868927-A1C3C8F6-155C-43F4-B08A-2661A062EE1A
page(s)	515-518
instance of	wds:Q69868927-5EF5ED99-4D30-49B1-A7DB-AF120E868C85
instance of	scholarly article
main subject	wds:Q69868927-4F561092-F683-4666-8F33-E0AFC211C6A8 wds:Q69868927-980A1DB5-EB55-4447-B896-B2A7ED29AC7A
main subject	anticoagulant thrombosis
PubMed ID	wds:Q69868927-D6970D0E-4BEA-4EB1-9A84-09974230781E
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/2863541
PubMed ID	2863541
published in	wds:Q69868927-3E6847BE-9962-438B-A4F5-A3928F53ACAD
published in	The Lancet
issue	wds:Q69868927-02AA6E08-2F85-4F77-8F47-F8ACE428C1D0
volume	wds:Q69868927-715DE0D4-A13A-4F23-AE79-94D4FA95B2BD
issue	8454
volume	2
DOI	wds:Q69868927-D395142D-A365-4FAA-928D-118C053492AB
DOI	http://dx.doi.org/10.1016/S0140-6736(85)90459-3
DOI	10.1016/S0140-6736(85)90459-3
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q69868927
is cites work of	DVT prophylaxis and anticoagulation in the surgical patient Use of oral anticoagulants in older patients Early outcome after isolated calf vein thrombosis Review of venous thromboembolism and race: the generalizability of treatment guidelines for high-risk populations Clot-bound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by antithrombin III-independent inhibitors Duration of treatment with vitamin K antagonists in symptomatic venous thromboembolism Duration of treatment with vitamin K antagonists in symptomatic venous thromboembolism Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines Venous Thromboembolism in Cancer: An Update of Treatment and Prevention in the Era of Newer Anticoagulants The National Comprehensive Cancer Center Network (NCCN) guidelines on the management of venous thromboembolism in cancer patients Prevention of thalidomide- and lenalidomide-associated thrombosis in myeloma Evidence-based management of anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines American Heart Association/American College of Cardiology Foundation guide to warfarin therapy Measuring the outcomes and pharmacoeconomic consequences of venous thromboembolism prophylaxis in major orthopaedic surgery Non-invasive diagnosis of venous thromboembolism in outpatients. Correlation between different intensities of anti-vitamin K treatment and coagulation parameters Value of assessment of pretest probability of deep-vein thrombosis in clinical management. Effect of patient's sex on risk of recurrent venous thromboembolism: a meta-analysis. Treatment of DVT: how long is enough and how do you predict recurrence Does the location of thrombosis determine the risk of disease recurrence in patients with proximal deep vein thrombosis? Developments in diagnosis and classification of venous disorders: non-invasive diagnosis Deep venous thrombosis: early discharge strategies and outpatient management Therapeutic ranges for oral anticoagulation in different thromboembolic disorders Current data on the treatment of venous thromboembolic disease Management of oral anticoagulants in the treatment of venous thromboembolism Recent advances in the management of venous thromboembolism. Prevention and treatment of venous thromboembolism Heparin and low-molecular-weight heparin in the treatment of venous thromboembolism Allastair B. Karmody Award. Calf vein thrombi are not a benign finding. Safety and efficacy of warfarin started early after submassive venous thrombosis or pulmonary embolism Anticoagulant drugs in the elderly: the risks usually outweight the benefits Sex differences in patients receiving anticoagulant therapy for venous thromboembolism Vitamin K antagonists or low-molecular-weight heparin for the long term treatment of symptomatic venous thromboembolism Derivation of the non-inferiority margin for the evaluation of direct oral anticoagulants in the treatment of venous thromboembolism Diagnosis of pulmonary embolism Guidance for the treatment of deep vein thrombosis and pulmonary embolism Preventive and therapeutic approach to venous thromboembolic disease and pulmonary embolism--can death from pulmonary embolism be prevented? Management of venous thromboembolism in the elderly Anticoagulants in older patients. A safety perspective Venous thrombosis and thromboembolism Colour Doppler ultrasound of the post-phlebitic limb: sounding a cautionary note Colour flow imaging of calf vein thrombosis Utility of leg ultrasonography in suspected symptomatic isolated calf deep venous thrombosis Pharmacotherapeutic aspects of unfractionated and low molecular weight heparins Pharmacokinetic optimisation of the treatment of deep vein thrombosis Pharmacokinetic and pharmacodynamic variability of fluindione in octogenarians Measuring quality of oral anticoagulation care: extending quality measurement to a new field. Oral heparin: status review Diagnosis of deep venous thrombosis and pulmonary embolism Should symptomatic, isolated distal deep vein thrombosis be treated with anticoagulation? The origin of lower extremity deep vein thrombi in acute venous thrombosis

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 190 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software